Complementing the diagnosis with the patients eyes. Tubulointersticial nephritis and Uveitis (TINU) syndrome
References
Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2004;19(1):8-11. doi: 10.1093/ndt/gfg464.
Clive DM, Vanguri VK. The Syndrome of Tubulointerstitial Nephritis with Uveitis (TINU). Am J Kidney Dis. 2018;72(1):118-128. doi: 10.1053/j.ajkd.2017.11.013.
Mann S, Seidman MA, Barbour SJ, Levin A, Carruthers M, Chen LY. Recognizing IgG4-related tubulointerstitial nephritis. Can J Kidney Health Dis. 2016;3:34. doi: 10.1186/s40697-016-0126-5MID.
McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015 Aug;94(32):e1366.
Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis. 2014;64(4):558-66. doi: 10.1053/j.ajkd.2014.04.027.
Okafor LO, Hewins P, Murray PI, Denniston AK. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors. Orphanet J Rare Dis. 2017;12(1):128. doi: 10.1186/s13023-017-0677-2.
Pinheiro MA, Rocha MB, Neri BO, Parahyba IO, Moura LA, Oliveira CM, et al. TINU syndrome: review of the literature and case report. J Bras Nefrol. 2016;38(1):132-6. doi: 10.5935/0101-2800.20160019.
Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol. 2000;54(3):179-90.
Zhang P, Cornell LD. IgG4-related tubulointerstitial nephritis. Adv Chronic Kidney Dis. 2017;24(2):94-100. doi: 10.1053/j.ackd.2016.12.001.
Copyright (c) 2020 Revista de Nefrología, Diálisis y Trasplante
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.